Exhibit 1280 ยท Statute
Food and Drug Administration Safety and Innovation Act, Pub. L. 112-144, Title I (Prescription Drug User Fee Amendments of 2012)
The Congress finds that the fees authorized by the amendments made in this title will be dedicated toward expediting the drug development process and the process for the review of human drug applications, including postmarket drug safety activities
Title I is the Prescription Drug User Fee Amendments of 2012 (PDUFA V). Approved 9 July 2012.
- Source
- United States Congress
- Date
- 9 July 2012
- Quoted from
- Sec. 101(b)
- Grade
- Primary record
- Document
- https://www.govinfo.gov/content/pkg/PLAW-112publ144/html/PLAW-112publ144.htm
- Accessed
- 2026-11-10
- Cited by
- Findings citing this exhibit